Audentes Therapeutics, Inc. Stock Split Ratio
Audentes Therapeutics, Inc. reported Stock Split Ratio of 222.98% for the 0-month period ending 2016-07-07, per its 10-K filed 2017-03-13.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2017-03-13
- 2016-07-07: Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 222.98%; Stockholders' Equity Note, Stock Split, Conversion Ratio 222.98%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|---|
| 2016-07-07 | 222.98% 10-K · filed 2017-03-13 | 222.98% 10-Q · filed 2016-11-10 |